Integer price target raised to $98 from $91 at BofA

BofA analyst Craig Bijou raised the firm’s price target on Integer (ITGR) to $98 from $91 and keeps a Neutral rating on the shares. Despite the Q1 revenue beat, the company cut its FY26 growth guidance, with a little over half of the cut being incremental change in EP procedure products that are not ablation related and the rest for risk adjusting Integer’s portfolio given desire to not have to cut again, the analyst tells investors in a research note. The firm added that Integer’s comments do not seem to suggest a change in EP procedure volumes overall, so it believes the reduction is mostly tied to customers’ mapping catheters.